Support may be useful before an FDA inspection, product launch, submission, or major operational change, and after observations, agency correspondence, a Form 483, or a Warning Letter. An FDA compliance consultant can help identify risks early, prioritize urgent gaps, and build a practical plan for corrective action before issues grow more difficult to manage. This approach can be scaled to a focused issue or broader program.